Company intelligence / Profile preview

Ecopharm

Ownership: Private
Development stage: Other

Overview

Ecopharm is a Ukrainian pharmaceutical company focused on developing and producing innovative herbal medicines. Its portfolio includes three original commercialized products—Proteflazid® (drops), Proteflazid® (suppositories), and Flavovir® (syrup)—with ongoing research into new dosage forms and expanded indications. Over 11,000 patients have participated in clinical studies involving its drugs, particularly for viral diseases.

Therapeutic areas: Infectious Diseases
Modalities: Small moleculeHerbal extract-based drugs
Industry: Biotech

Beyond the preview

Go deeper on Ecopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecopharm.